Santen Pharmaceutical Co., Ltd.

SNPHY · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$63,560$84,578$92,997$77,851
Short-Term Investments$2,524$0$997$0
Receivables$62,691$67,398$71,759$69,066
Inventory$59,282$59,247$51,590$49,998
Other Curr. Assets$7,091$10,195$6,957$8,223
Total Curr. Assets$195,148$221,418$224,300$205,138
Property Plant & Equip (Net)$74,812$72,715$72,954$74,387
Goodwill$0$0$0$0
Intangibles$77,583$73,677$75,467$79,612
Long-Term Investments$0$0$26,539$28,940
Tax Assets$10,614$0$10,017$0
Other NC Assets$30,979$40,313$1$10,230
Total NC Assets$193,988$186,705$184,978$193,169
Other Assets$1$0-$1$0
Total Assets$389,137$408,123$409,277$398,307
Liabilities
Payables$30,612$42,361$38,989$35,791
Short-Term Debt$0$0$3,289$0
Tax Payable$3,092$0$2,239$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$39,873$44,070$42,320$42,738
Total Curr. Liab.$73,577$86,431$86,837$78,529
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$2,709$0$2,606$0
Other NC Liab.$39,244$41,478$34,653$36,567
Total NC Liab.$41,953$41,478$37,259$36,567
Other Liabilities$0$0$0$0
Cap. Leases$0$0$3,015$0
Total Liabilities$115,530$127,909$124,096$115,096
Equity
Pref Stock$0$0$0$0
Common Stock$8,816$8,808$8,806$8,797
Retained Earnings$235,744$227,682$228,291$227,374
AOCI$330$43,944$40,509$47,841
Other Equity$30,207$831$8,636$16
Total Equity$274,767$281,265$286,242$284,028
Supplemental Information
Minority Interest-$1,160-$1,051-$1,061-$817
Total Liab. & Tot. Equity$389,137$408,123$409,277$398,307
Net Debt-$63,560-$84,578-$89,708-$77,851